TY - JOUR
T1 - A study of muscarinic receptor heterogeneity with weak antagonists
AU - Fisher, Abraham
AU - Grunfeld, Yona
AU - Weinstock, Marta
AU - Gitter, Simon
AU - Cohen, Sasson
PY - 1976/7
Y1 - 1976/7
N2 - A study of heterogeneity among muscarinic receptors was carried out with new rigid molecules, comprising structures in the fused quinuclidine-valerolactone, quinuclidine-cyclohexenone, quinuclidine-cyclohexanone and quinuclidine-cyclohexane derivatives. These are structurally related to the potent muscarinic agent, 3-acetoxyquinuclidine but substantially different from it in conformation. All proved to antagonize acetylcholine-like activity, but to a different extent in different systems. The equipotent molar ratio with respect to atropine (as 1) was: isolated guinea pig ileum, 10,000-1,000; salivary gland (mouse), 1000-100; superior cervical ganglion (cat), 100-10; CNS (mouse), ∼10. It is suggested that the rigid structure induces a three-point constrained fit in the receptor (onium group, hydrophobic moiety and carbonyl group), but that not all muscarinic receptors are capable of responding equally. In this case, receptor specificity of the drug is a direct consequence of its graded departure from the preferred conformation of acetylcholine and, therefore, is necessarily associated with partial loss of potency.
AB - A study of heterogeneity among muscarinic receptors was carried out with new rigid molecules, comprising structures in the fused quinuclidine-valerolactone, quinuclidine-cyclohexenone, quinuclidine-cyclohexanone and quinuclidine-cyclohexane derivatives. These are structurally related to the potent muscarinic agent, 3-acetoxyquinuclidine but substantially different from it in conformation. All proved to antagonize acetylcholine-like activity, but to a different extent in different systems. The equipotent molar ratio with respect to atropine (as 1) was: isolated guinea pig ileum, 10,000-1,000; salivary gland (mouse), 1000-100; superior cervical ganglion (cat), 100-10; CNS (mouse), ∼10. It is suggested that the rigid structure induces a three-point constrained fit in the receptor (onium group, hydrophobic moiety and carbonyl group), but that not all muscarinic receptors are capable of responding equally. In this case, receptor specificity of the drug is a direct consequence of its graded departure from the preferred conformation of acetylcholine and, therefore, is necessarily associated with partial loss of potency.
KW - Quinuclidine-cyclohexane
KW - Quinuclidine-cyclohexanone, fused
KW - Quinuclidine-cyclohexenone
KW - Quinuclidine-valerolactone, fused
KW - Receptor-specific antagonists
UR - http://www.scopus.com/inward/record.url?scp=84886610246&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(76)90209-0
DO - 10.1016/0014-2999(76)90209-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84886610246
SN - 0014-2999
VL - 38
SP - 131
EP - 139
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -